molecules of the month


non-immunosuppressive cyclophilin inhibitor

oral activity in humanized HCV model

from semisynthetic deriv. of FR901459

Bioorg. Med. Chem. Lett., Jun. 2, 2020

Astellas Pharma, Ibaraki, JP

Structure of ASP-5286
1 min read

ASP5286 is an analog of the natural product cyclosporin A that maintains the anti-HCV activity of cyclosporin A by binding to cyclophilin, but was optimized to be less immunosuppresive than cyclosporin A. The macrocycle was identified through semisynthetic derivitization of a related natural product, FR901459. The Astellas team was able to optimize compounds from immunosuppresive compounds with poor oral exposure to the non-immunosuppressive clinical candidate 5286 with oral activity in a mouse humanized liver HCV model.

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: